Advair diskus 100/50 and Obliterative bronchiolitis - a phase IV clinical study of FDA data

Summary:

Obliterative bronchiolitis is reported as a side effect among people who take Advair diskus 100/50 (fluticasone propionate; salmeterol xinafoate), especially for people who are female, 50-59 old, also take Levaquin, and have Acute myeloid leukaemia.

The phase IV clinical study analyzes which people have Obliterative bronchiolitis when taking Advair diskus 100/50. It is created by eHealthMe based on reports of 38,800 people who have side effects when taking Advair diskus 100/50 from the FDA, and is updated regularly.

What is Advair diskus 100/50?

Advair diskus 100/50 has active ingredients of fluticasone propionate; salmeterol xinafoate. It is often used in asthma. eHealthMe is studying from 39,246 Advair diskus 100/50 users. Check the latest studies of Advair diskus 100/50.

What is Obliterative bronchiolitis?

Obliterative bronchiolitis (bronchiolar inflammation) is found to be associated with 164 drugs and 489 conditions by eHealthMe. Check the latest studies of Obliterative bronchiolitis.

On Jul, 06, 2026

38,800 people reported to have side effects when taking Advair diskus 100/50.
Among them, 12 people (0.03%) have Obliterative bronchiolitis.

Could Advair diskus 100/50 cause Obliterative bronchiolitis?

Among these 12 people:

What is the gender of people who have Obliterative bronchiolitis when taking Advair diskus 100/50? *

female: 100 %
male: 0.0 %

What is the age of people who have Obliterative bronchiolitis when taking Advair diskus 100/50? *

What are other drugs people take besides Advair diskus 100/50? *

What are other side effects people have besides Obliterative bronchiolitis? *

Interstitial Lung Disease: 6 people, 50.00%
Pneumonia: 4 people, 33.33%
Temporomandibular Joint Syndrome (pain at the temporomandibular joint due to various causes of increased muscle tension and spasm. it is believed that syndrome is a physical manifestation of psychological stress): 4 people, 33.33%
Anaemia Postoperative: 4 people, 33.33%
Aseptic Necrosis (the death of bone tissue due to a lack of blood supply): 4 people, 33.33%
Resorption Bone Increased: 4 people, 33.33%
Fungal Infection: 4 people, 33.33%
Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs): 4 people, 33.33%
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 4 people, 33.33%
Osteopenia (a condition where bone mineral density is lower than normal): 4 people, 33.33%

What are the existing conditions these people have? *

Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 4 people, 33.33%
Urethral Pain: 2 people, 16.67%
Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 2 people, 16.67%
Stress And Anxiety: 2 people, 16.67%
Osteoporosis (bones weak and more likely to break): 2 people, 16.67%
Nausea And Vomiting: 2 people, 16.67%
Nausea (feeling of having an urge to vomit): 2 people, 16.67%
Nasal Congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels): 2 people, 16.67%
Muscle Aches (muscle pain): 2 people, 16.67%
Itching: 2 people, 16.67%

* Approximation only. Some reports may have incomplete information.

Do you take Advair diskus 100/50 and have Obliterative bronchiolitis?

- Check whether Obliterative bronchiolitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Advair diskus 100/50:

Advair diskus 100/50 (39,246 reports)

Obliterative bronchiolitis treatments and more:

Obliterative bronchiolitis (2,040 reports)

How severe was Obliterative bronchiolitis and when was it recovered:

Obliterative bronchiolitis in Advair diskus 100/50

Expand to all the drugs that have ingredients of fluticasone propionate; salmeterol xinafoate:

Obliterative bronchiolitis and drugs with ingredients of fluticasone propionate; salmeterol xinafoate (18 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Advair diskus 100/50:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Obliterative bronchiolitis:

Obliterative bronchiolitis (164 drugs)

Browse all the conditions that are associated with Obliterative bronchiolitis:

Obliterative bronchiolitis (489 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on fluticasone propionate; salmeterol xinafoate (the active ingredients of Advair diskus 100/50) and Advair diskus 100/50 (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.